Feb. 26 at 6:26 PM
$GALT Calling it “Phase 3” is normal positioning, not a hidden signal. NAVIGATE is a seamless 2b/3 trial, and once in the confirmatory portion, companies often just refer to it as Phase 3 — especially at KOL events.
If there were something major (NDA filing, breakthrough designation, database lock, or hitting a primary endpoint), they would state that clearly.
The more important line is “reinforce and extend previously reported findings,” which suggests updated or expanded data — likely subgroup or follow-up analysis — not a brand new pivotal readout.
Overall: not a mistake, not a secret, probably incremental rather than catalytic.
Giving a different view as some people are blinded by anything. Regardless great to hear something new today.
